Quanterix announced on January 10th that it has entered into an agreement to acquire Akoya Biosciences in an all-stock transaction. This strategic move is aimed at expanding Quanterix's capabilities in the life sciences sector, particularly in the field of spatial biology. However, the market has reacted negatively to the news, as investors appear concerned about the potential dilution of shares and the int
Quanterix Corporation (QTRX) is experiencing a modest uptick in its stock price following the announcement that David R. Walt, co-inventor of the company's Simoa technology, has been awarded the National Medal of Technology and Innovation. This prestigious accolade, presented by the President of the United States, is the nation's highest honor for technological achievement and underscores the impact of Quan
Quanterix Corporation (QTRX) is experiencing downward pressure in after-hours trading following the announcement of a securities class action investigation by Rosen Law Firm. The investigation is probing potential securities claims on behalf of shareholders, stemming from allegations that Quanterix may have issued materially misleading business information. This development has raised concerns among investo
Quanterix Corporation's stock is experiencing downward pressure following the announcement by Rosen Law Firm on December 16, 2024, that it is investigating potential securities claims against the company. The investigation stems from allegations that Quanterix may have issued materially misleading business information to investors. This development follows a previous disclosure by Quanterix on November 12,
Quanterix Corporation's stock is experiencing a decline following the announcement of its acquisition of EMISSION, a manufacturer of magnetic beads for diagnostic assays. The deal, valued at $10 million upfront with potential additional payments of up to $60 million based on performance milestones, is expected to close in January 2025. While the acquisition is strategically aimed at vertically integrating E